Log In
Print this Print this

GSO targeting APOB

  Manage Alerts
Collapse Summary General Information
Company Idera Pharmaceuticals Inc.
DescriptionGene-silencing oligonucleotide (GSO) targeting apolipoprotein B (APOB)
Molecular Target Apolipoprotein B (APOB)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPreclinical
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat cardiovascular disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today